These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Simard JM; Yurovsky V; Tsymbalyuk N; Melnichenko L; Ivanova S; Gerzanich V Stroke; 2009 Feb; 40(2):604-9. PubMed ID: 19023097 [TBL] [Abstract][Full Text] [Related]
5. [Effects of sulfonylureas on patients with type 2 diabetes and acute nonlacunar ischemic stroke]. Chen DM; Yu YR Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):810-3. PubMed ID: 25341346 [TBL] [Abstract][Full Text] [Related]
6. [Sulfonylurea drugs for type 2 diabetes]. Toyota T Nihon Rinsho; 2002 Sep; 60 Suppl 9():339-45. PubMed ID: 12387015 [No Abstract] [Full Text] [Related]
7. [Polymorphism of the sulfonylurea receptor gene in type 2 diabetes mellitus]. Owecki M; Horst-Sikorska W; Kaczmarek M; Słomski R; Sowiński J Pol Arch Med Wewn; 2003 Feb; 109(2):143-8. PubMed ID: 12879777 [TBL] [Abstract][Full Text] [Related]
8. Sulfonylurea drugs do not influence initial stroke severity and in-hospital outcome in stroke patients with diabetes. Weih M; Amberger N; Wegener S; Dirnagl U; Reuter T; Einhäupl K Stroke; 2001 Sep; 32(9):2029-32. PubMed ID: 11546892 [TBL] [Abstract][Full Text] [Related]
12. [Sulfonylurea receptors and their interaction with glimepiride]. Zueva NA; Sologub NV; Efimov AS Lik Sprava; 2003; (2):35-9. PubMed ID: 12774471 [TBL] [Abstract][Full Text] [Related]
13. SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics. Tayek J Diabetes Obes Metab; 2008 Nov; 10(11):1128-9; author reply 1129-30. PubMed ID: 18671799 [No Abstract] [Full Text] [Related]
14. Sulfonylurea use before stroke does not influence outcome. Favilla CG; Mullen MT; Ali M; Higgins P; Kasner SE; Stroke; 2011 Mar; 42(3):710-5. PubMed ID: 21330623 [TBL] [Abstract][Full Text] [Related]
15. ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas. Sato R; Watanabe H; Genma R; Takeuchi M; Maekawa M; Nakamura H Pharmacogenomics; 2010 Dec; 11(12):1743-50. PubMed ID: 21142918 [TBL] [Abstract][Full Text] [Related]
16. Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration. Engler RL; Yellon DM Circulation; 1996 Nov; 94(9):2297-301. PubMed ID: 8901685 [No Abstract] [Full Text] [Related]